| COMPOSITION: | Each Film coated tablet contains Dapagliflozin 10 mg & Sitagliptin 50 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | DAPAFORD-S 50 tablets contain Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. This combination helps lower blood sugar levels in patients with type 2 diabetes by increasing glucose excretion through urine and enhancing insulin secretion. It is prescribed to improve glycemic control along with diet and exercise. |
| SIDE EFFECTS: | It is generally well tolerated. The main side effects may include urinary tract infections, genital infections, headache, nasopharyngitis, increased urination, and gastrointestinal discomfort. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
